|
483 Suggests Disregard for FDA Procedures, Recordkeeping
An FDA inspection of Salt Lake City-based BioMeridian International found 16 observations — most in the form of missing procedures or documentation.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives